Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Organoids × Methotrexate × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 203 Leukemia 153 Lymphoma 109 Leukemia, Myeloid, Acute 83 Burkitt Lymphoma 74 Myelodysplastic Syndromes 65 Breast Neoplasms 55 Lymphoma, Non-Hodgkin 53 Lymphoma, Large B-Cell, Diffuse 51 Graft vs Host Disease 40 Lymphoma, Mantle-Cell 39 Leukemia, Lymphocytic, Chronic, B-Cell 39 Lymphoma, Follicular 38 Leukemia, Myeloid, Accelerated Phase 36 Hodgkin Disease 35 Leukemia, Myeloid, Chronic-Phase 32 Leukemia, Myelomonocytic, Chronic 30 Blast Crisis 30 Myeloproliferative Disorders 28 Multiple Myeloma 28 Congenital Abnormalities 28 Recurrence 27 Lymphoma, Large-Cell, Immunoblastic 27 Leukemia, Biphenotypic, Acute 27 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 25 Osteosarcoma 25 Lymphoma, B-Cell, Marginal Zone 25 Primary Myelofibrosis 22 Dendritic Cell Sarcoma, Interdigitating 22 Hematologic Neoplasms 21

Interventions

pyrrolidine 1 pirarubicin 1 olaparib 1 ixabepilone 1 exemestane 1 eribulin 1 apatinib 1 Vinorelbine 1 Trastuzumab 1 Toremifene 1 Tamoxifen 1 Paclitaxel 1 Methotrexate 1 Letrozole 1 Gemcitabine 1 Fulvestrant 1 Fluorouracil 1 Epirubicin 1 Endostatins 1 Doxorubicin 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Capecitabine 1 Bevacizumab 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03925233 2019-04-24

Breast Cancer Treatment Based on Organ-like Culture

Xijing Hospital

Breast Cancer Organoids

Data powered by HemOnc (CC BY 4.0) Colophon ⚡